|
|
| WEEKLY e-ALERT [ PREMIUM EDITION ] |
| Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China¡¯s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies. Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China (Web Edition) as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line. |
| Expert Opinions |
 |
 |
Investing in Government Affairs to Access Your Market Potential in China: Key Considerations(2/2/2012 ) (Premium) |
| Government affairs expert Jonathan Zhu observes a common organization "flaw" in life science companies to underestimate the importance of the government affairs (GA) function in China and explains how businesses should appropriately assess their needs and structure this function. |
| Industry News |
|
|
Transgene steps up presence and R&D in China(1/31/2012 ) (Premium) |
| Transgene has set up its subsidiary Transgene Biopharmaceuticals Technology in Shanghai. It has a staff of five people. |
|
MOH and Novo Nordisk forms government-private partnership for diabetes education(1/30/2012 ) (Premium) |
| The News & Promotion Center under the Ministry of Health (MOH), the China Health Education Center and Novo Nordisk signed a memorandum of understanding recently to collaborate on diabetes education in China. |
| Regulatory News |
|
|
CDE initiates regulation of clinical data management at its symposium for clinical data standards(1/30/2012 ) (Premium) |
| The symposium discussed about contemporary issues and plans for China's clinical data management and standards, roadmap for establishing/streamlining relevant regulations, and priority tasks. |
| Legal/IPR News |
|
|
SFDA terminates administrative protection of two Roche products(2/1/2012 ) (Premium) |
| SFDA issued two announcements to terminate the administrative protection for Roche's Bonviva injection and tablets. |
|
Chinese expert calls for revision of the Drug Administration Law(1/31/2012 ) (Premium) |
| Chinese expert with the Chinese Academy of Social Sciences recently proposed to revise the Drug Administration Law of China in order to deal with various flaws, ambiguities and deficiencies of the Chinese drug regulatory system. The topic receive considerable media attention. |
|
Drug salesman and physicians sentenced to prison for corruption in Beijing(1/30/2012 ) (Premium) |
| Wang Zunhe, an independent pharmaceutical sales operator, was sentenced to 15 years in prison and a fine of CNY 100,000 recently after he was found guilty of bribing heads and physicians of eight tuberculosis prevention and treatment clinics in Beijing. |
| People in the News |
|
|
Senior BMI official in Nanjing handed prison sentence for corruption(2/1/2012 ) (Premium) |
| Wang Fuhua, formerly Director of Nanjing Municipal Medical Insurance Settlement Administrative Center and Director of the Medical Insurance Division of Nanjing Municipal Labor Department, was sentenced to six years in prison for corruption recently. |
|
Recent executive moves(1/31/2012 ) (Premium) |
| Various new China-related pharma executive appointments took place in January 2012. |
| © Wicon International Group¡¡Support by: www.heightow.com | Home | Site map | Contact Us | Links |